Literature DB >> 19454401

The influence of different types of alcoholic beverages on disrupting highly active antiretroviral treatment (HAART) outcome.

María José Míguez-Burbano1, John E Lewis, Joel Fishman, Deshratn Asthana, Robert M Malow.   

Abstract

AIMS: Studies have yielded conflicting results regarding alcohol's influence on HIV outcomes, particularly after highly active antiretroviral treatment (HAART). Discrepant findings may be related to confounding variables, including gender, patterns of alcohol abuse and type of alcohol beverage beyond the amount consumed.
METHODS: Using a cohort study, differences in HAART effectiveness after 24 weeks of therapy were compared as a function of amount and preference for alcohol, drinking only liquor (LI, n = 55) or only wine or beer (BW, n = 110). Given the critical role of thymus on HAART response, changes in thymus size, CD4s, naïve lymphocytes and viral loads were assessed.
RESULTS: After HAART, positive increases in both CD4s (+12 cell counts/mm(3)) and thymus size (+0.7 mm(3)) were evident in the BW group. In contrast, the LI subgroup exhibited a decline in both parameters (-4 CD4 cells/mm(3) and -0.6 mm(3) in thymus size). Women in the LI group exhibited significantly lower CD4 (163.4 +/- 46.2) and naïve counts (178 +/- 69.5) than LI men (CD4: 281.6 +/- 203, P = 0.05; lymphocytes: 301.4 +/- 198, P = 0.04). In adjusted regression models, the LI compared to the BW subgroup had greater odds of maintaining detectable viral loads (RR = 1.35, 95% CI 1.04-1.75; P = 0.03), increased thymus volumes (RR = 3.8, P = 0.04) and replenished naïve cells (RR = 13, P = 0.02).
CONCLUSIONS: Liquor was associated with thymus deterioration and thus with poorer viro-immune outcomes after HAART. Subtyping participants by alcohol consumption patterns seems to be clinically relevant and needs to be accounted for in future studies.

Entities:  

Mesh:

Year:  2009        PMID: 19454401      PMCID: PMC2732915          DOI: 10.1093/alcalc/agp024

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  41 in total

1.  Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients?

Authors:  P Fabris; G Tositti; V Manfrin; M T Giordani; A Vaglia; A M Cattelan; A Carlotto
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

2.  Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

Authors:  Nancy A Hessol; Ann Kalinowski; Lorie Benning; Joanne Mullen; Mary Young; Frank Palella; Kathryn Anastos; Roger Detels; Mardge H Cohen
Journal:  Clin Infect Dis       Date:  2006-12-12       Impact factor: 9.079

3.  Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.

Authors:  M Roederer; F J Staal; P A Raju; S W Ela; L A Herzenberg; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Problem drinking and medication adherence among persons with HIV infection.

Authors:  R L Cook; S M Sereika; S C Hunt; W C Woodward; J A Erlen; J Conigliaro
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

5.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

Review 6.  Expanding research on the role of alcohol consumption and related risks in the prevention and treatment of HIV/AIDS.

Authors:  Kendall J Bryant
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

7.  Alcohol intake and the risk of lung cancer: influence of type of alcoholic beverage.

Authors:  E Prescott; M Grønbaek; U Becker; T I Sørensen
Journal:  Am J Epidemiol       Date:  1999-03-01       Impact factor: 4.897

8.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Intake of beer, wine, and spirits and risk of stroke : the copenhagen city heart study.

Authors:  T Truelsen; M Gronbaek; P Schnohr; G Boysen
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

10.  Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.

Authors:  P A Raju; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  AIDS Res Hum Retroviruses       Date:  1994-08       Impact factor: 2.205

View more
  15 in total

Review 1.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

Review 2.  Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.

Authors:  Oluwatosin O Ogedengbe; Edwin C S Naidu; Onyemaechi O Azu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

3.  Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.

Authors:  Katie Taylor-Smith; Hannock Tweya; Anthony Harries; Erik Schoutene; Andreas Jahn
Journal:  Malawi Med J       Date:  2010-06       Impact factor: 0.875

4.  Effects of Heavy Drinking on T-Cell Phenotypes Consistent with Immunosenescence in Untreated HIV Infection.

Authors:  Kaku A So-Armah; E Jennifer Edelman; Debbie M Cheng; Margaret F Doyle; Gregory J Patts; Natalia Gnatienko; Evgeny M Krupitsky; Jeffrey H Samet; Matthew S Freiberg
Journal:  Alcohol Clin Exp Res       Date:  2016-07-08       Impact factor: 3.455

5.  Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States.

Authors:  Rachelle Reid; Sannisha K Dale
Journal:  AIDS Care       Date:  2021-11-16

Review 6.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

7.  Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda.

Authors:  Stephen B Asiimwe; Robin Fatch; Gregory Patts; Michael Winter; Christine Lloyd-Travaglini; Nneka Emenyonu; Winnie Muyindike; Allen Kekibiina; Elena Blokhina; Natalia Gnatienko; Evgeny Kruptisky; Debbie M Cheng; Jeffrey H Samet; Judith A Hahn
Journal:  AIDS Behav       Date:  2017-11

8.  Cholesterol as a Mediator of Alcohol-Induced Risks for Respiratory Disease Hospitalizations among People Living With HIV.

Authors:  María José Míguez; Rhonda Rosenberg; Ximena Burbano; Robert Malow
Journal:  J AIDS Clin Res       Date:  2011-10-21

9.  Beyond the Brain: The Role of Brain-Derived Neurotrophic Factor in Viroimmune Responses to Antiretroviral Therapy among People Living with HIV with and without Alcohol Use.

Authors:  María José Míguez-Burbano; Luis Espinoza; Diego Bueno; Mayra Vargas; Allison B Trainor; Clery Quiros; John E Lewis; Deshratn Asthana
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-05-16

10.  Alcohol Consumption, Progression of Disease and Other Comorbidities, and Responses to Antiretroviral Medication in People Living with HIV.

Authors:  Manuela G Neuman; Michelle Schneider; Radu M Nanau; Charles Parry
Journal:  AIDS Res Treat       Date:  2012-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.